Seelos Therapeutics, Inc. focuses on the development of products addressing needs in CNS disorders and rare diseases.
peer of
investor of
competitor of
Metrics
marketPRIVATE
msh_idCOM:SEELOSTHERAPEUTICS
localeus
websitehttps://seelostherapeutics.com/
source_ref5b2debef-2a46-4eb2-b14f-f10e2403a34b
products_or_servicesDevelopment of therapeutics targeting CNS disorders and rare diseases, including products like SLS-002, SLS-004, SLS-005, SLS-007, and SLS-009.
United States